Vericel Q1 FY26 net loss narrows to $6.3 million; revenue rises 30% to $68.4 million

Vericel Corporation

Vericel Corporation

VCEL

0.00
  • Vericel first-quarter revenue rose 30% to USD 68.4 million, driven by MACI up 22% to USD 56.4 million.
  • Net loss narrowed to USD 6.3 million, or USD 0.12 per diluted share; gross margin improved 3 percentage points to 72%.
  • Adjusted EBITDA more than doubled to USD 9.6 million; free cash flow swung to USD 15.1 million.
  • Burn Care revenue climbed 91% to USD 12.0 million, with Epicel revenue up 119% to USD 10.9 million.
  • Full-year revenue outlook raised by USD 10 million to USD 326 million-USD 336 million, while gross margin guidance was reaffirmed at about 75%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vericel Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605070745PRIMZONEFULLFEED9714815) on May 07, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.